HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ lamivudine /dolutegravir (TLD) roll-out in Mozambique

Abstract Background The World Health Organization (WHO) recommends that HIV treatment scale-up is accompanied by a robust assessment of drug resistance emergence and transmission. The WHO HIV Drug Resistance (HIVDR) monitoring and surveillance strategy includes HIVDR testing in adults both initiatin...

Description complète

Détails bibliographiques

Auteurs principaux:	Nália Ismael, Hernane Gemusse, Isabel Mahumane, Osvaldo Laurindo, Cacildo Magul, Cheryl Baxter, Eduan Wilkinson, L. Marije Hofstra, Nick Wagar, Dulce Bila, Nédio Mabunda, Juliana da Silva, Túlio de Oliveira, Elliot Raizes, Wolfgang Preiser, Pedro Manuel, Artur Ramos, Adolfo Vúbil
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2024-07-01
Collection:	BMC Infectious Diseases
Sujets:	HIV Drug resistance Acquired and pre-treatment
Accès en ligne:	https://doi.org/10.1186/s12879-024-09579-4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!